← Back to All Filings

Utpal Koppikar Joins INSMED Inc Board of Directors with Zero Initial Beneficial Ownership

Low SignificanceOctober 20, 2026 at 9:38:01 PM UTC

INSMED Inc

$INSM3CIK: 0001104506

Subscribe to track INSM

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Initial Statement of Beneficial Ownership (Form 3) Company: INSMED Inc ($INSM) Insider: Utpal Koppikar (Director) Event Date: October 19, 2026 Shares Held: 0 Significance: Low (Initial filing, no securities owned)

Comprehensive Analysis

Executive Summary

On October 20, 2026, Utpal Koppikar filed an initial Form 3 statement of beneficial ownership for INSMED Inc ($INSM) reflecting his status as a newly appointed member of the Board of Directors, effective October 19, 2026. The filing indicates that Mr. Koppikar holds no initial direct or indirect equity securities or derivative positions in the company at the time of appointment.

Filing Details

  • Reporting Person: Utpal Koppikar (CIK: 0001742696)
  • Relationship: Director
  • Event Date: October 19, 2026
  • Reported Holdings: No securities beneficially owned (<noSecuritiesOwned>1</noSecuritiesOwned>)
  • Exhibit: Exhibit 24 (Limited Power of Attorney for SEC Reporting Purposes)

Market & Governance Context

This filing is a routine initial disclosure under Section 16(a) of the Securities Exchange Act of 1934 following an individual's election or appointment to the board. Because there were no active open-market transactions or prior shareholdings disclosed, this filing represents low trading significance. Future equity compensation or open-market transactions will be monitored via subsequent Form 4 disclosures.

Topics:#INSM#Insmed#Form3#InsiderReporting#CorporateGovernance#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.